Ludwig-Boltzmann-Institut für COPD und Pneumologische Epidemiologie
Welcome,         Profile    Billing    Logout  
 6 Trials 
10 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Valipour, Arschang
BLOC, NCT05911009 / 2022-003452-14: To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID

Completed
2
119
Europe
BC 007 or matching placebo
Berlin Cures GmbH, Berlin Cures GmbH
Long Covid
06/24
09/24
NCT06035120: An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

Recruiting
N/A
200
Europe, US, RoW
AeriSeal System
Pulmonx Corporation
Emphysema, Pulmonary, Emphysema or COPD
06/27
03/28
NCT06522334: Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria

Recruiting
N/A
400
Europe
Ludwig Boltzmann Institute for Lung Health
Interstitial Lung Disease
02/34
02/34
RheSolve, NCT04677465: Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis

Active, not recruiting
N/A
270
Europe, US
RheOx Bronchial Rheoplasty, Sham Procedure
Gala Therapeutics, Inc.
Chronic Bronchitis
05/24
10/25
AIRFLOW-3, NCT03639051: Evaluation of the Safety and Efficacy of TLD in Patients with COPD

Active, not recruiting
N/A
464
Europe, US
Targeted Lung Denervation (TLD), TLD, TLD Therapy, Optimal Medical Care
Nuvaira, Inc.
COPD
10/24
09/28
NCT04182841: RheOx Registry Study in Europe

Recruiting
N/A
100
Europe
RheOx
Gala Therapeutics, Inc.
Chronic Bronchitis, COPD
12/24
12/25
NCT06655428: The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema

Recruiting
N/A
30
Europe
Endobronchial Therman Liquid Ablation (ETLA), Bronchoscopic lung volume reduction
Morair Medtech, LLC
Emphysema or COPD, Emphysema, Emphysema, Pulmonary, COPD, COPD (Chronic Obstructive Pulmonary Disease)
02/26
05/26
BREATHE-2, NCT05949645: Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema

Active, not recruiting
N/A
30
Europe
Apreo Implant Group
Apreo Health, Inc.
Emphysema or COPD
10/24
06/26
NCT03318406: Post-Market BTVA Registry

Recruiting
N/A
300
Europe
Bronchoscopic Thermal Vapor Ablation, BTVA, InterVapor
Uptake Medical Technology, Inc.
Emphysema or COPD
12/27
12/30
VAPORIZED, NCT03514329: Vapor Ablation for Localized Cancer Lesions

Not yet recruiting
N/A
10
Europe
Bronchoscopic Thermal Vapor Ablation, BTVA-C
Uptake Medical Technology, Inc.
Non Small Cell Lung Cancer, Metastatic Lung Cancer, Lung Cancer
03/28
06/28
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Valipour, Arschang
BLOC, NCT05911009 / 2022-003452-14: To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID

Completed
2
119
Europe
BC 007 or matching placebo
Berlin Cures GmbH, Berlin Cures GmbH
Long Covid
06/24
09/24
NCT06035120: An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

Recruiting
N/A
200
Europe, US, RoW
AeriSeal System
Pulmonx Corporation
Emphysema, Pulmonary, Emphysema or COPD
06/27
03/28
NCT06522334: Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria

Recruiting
N/A
400
Europe
Ludwig Boltzmann Institute for Lung Health
Interstitial Lung Disease
02/34
02/34
RheSolve, NCT04677465: Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis

Active, not recruiting
N/A
270
Europe, US
RheOx Bronchial Rheoplasty, Sham Procedure
Gala Therapeutics, Inc.
Chronic Bronchitis
05/24
10/25
AIRFLOW-3, NCT03639051: Evaluation of the Safety and Efficacy of TLD in Patients with COPD

Active, not recruiting
N/A
464
Europe, US
Targeted Lung Denervation (TLD), TLD, TLD Therapy, Optimal Medical Care
Nuvaira, Inc.
COPD
10/24
09/28
NCT04182841: RheOx Registry Study in Europe

Recruiting
N/A
100
Europe
RheOx
Gala Therapeutics, Inc.
Chronic Bronchitis, COPD
12/24
12/25
NCT06655428: The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema

Recruiting
N/A
30
Europe
Endobronchial Therman Liquid Ablation (ETLA), Bronchoscopic lung volume reduction
Morair Medtech, LLC
Emphysema or COPD, Emphysema, Emphysema, Pulmonary, COPD, COPD (Chronic Obstructive Pulmonary Disease)
02/26
05/26
BREATHE-2, NCT05949645: Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema

Active, not recruiting
N/A
30
Europe
Apreo Implant Group
Apreo Health, Inc.
Emphysema or COPD
10/24
06/26
NCT03318406: Post-Market BTVA Registry

Recruiting
N/A
300
Europe
Bronchoscopic Thermal Vapor Ablation, BTVA, InterVapor
Uptake Medical Technology, Inc.
Emphysema or COPD
12/27
12/30
VAPORIZED, NCT03514329: Vapor Ablation for Localized Cancer Lesions

Not yet recruiting
N/A
10
Europe
Bronchoscopic Thermal Vapor Ablation, BTVA-C
Uptake Medical Technology, Inc.
Non Small Cell Lung Cancer, Metastatic Lung Cancer, Lung Cancer
03/28
06/28

Download Options